Tag: EMERALD

Emapalumab rapidly controls MAS in patients with Still’s disease

Presented By
Dr Alexei Grom, Cincinnati Children's Hospital, OH, USA
Trial
NI-0501-06, EMERALD
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 11:17

Treatment options beyond CDK4/6 inhibition

Presented By
Dr Erica Mayer (Dana-Farber Cancer Institute, MA, USA); Prof. Virginia Kaklamani (University of Texas Health Sciences Center, TX, USA);
Trial
PACE; EMERALD; SERENA-2; CAPItello-291; VERITAC
Conference
SABCS 2022
Type
Peer-reviewed article

1 February 2023 18:03

The SERD elacestrant improves outcomes for patients unresponsive to endocrine therapy

Presented By
Dr Aditya Bardia, Massachusetts General Hospital, MA, USA
Trial
Phase 3, EMERALD
Conference
SABCS 2021
Type
Peer-reviewed article

31 January 2022 17:29

SABCS 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
SABCS 2021

10 January 2022 20:59
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com